ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,307.01
-0.27%
Dow Jones
39,671.04
-0.51%
US Dollar vs MXN
16.66252
-0.01%
Brent Oil
82.295
0.94%
Bitcoin
69,927.47
1.19%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cancer Genetics Inc (CGIX)

  7. Cancer Genetics Inc (CGIX) Noticias

CGIX

Cancer Genetics (CGIX)

Cancer Genetics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CGIX
FechaHoraFuenteTítuloSímboloCompañía
15/05/202307:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CGIXCancer Genetics Inc
10/05/202307:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CGIXCancer Genetics Inc
04/05/202315:33Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:CGIXCancer Genetics Inc
28/03/202305:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CGIXCancer Genetics Inc
24/03/202308:05Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CGIXCancer Genetics Inc
24/03/202307:35Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CGIXCancer Genetics Inc
19/01/202315:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CGIXCancer Genetics Inc
14/11/202215:46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CGIXCancer Genetics Inc
15/08/202207:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:CGIXCancer Genetics Inc
14/06/202215:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CGIXCancer Genetics Inc
03/06/202215:06Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CGIXCancer Genetics Inc
12/05/202208:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:CGIXCancer Genetics Inc
29/04/202216:46Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:CGIXCancer Genetics Inc
11/04/202205:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CGIXCancer Genetics Inc
30/03/202206:39Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CGIXCancer Genetics Inc
14/02/202212:04Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CGIXCancer Genetics Inc
11/02/202206:37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CGIXCancer Genetics Inc
29/12/202115:31Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CGIXCancer Genetics Inc
18/05/202105:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CGIXCancer Genetics Inc
01/04/202118:02Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CGIXCancer Genetics Inc
31/03/202105:30GlobeNewswire Inc.Cancer Genetics and StemoniX Announce Merger ClosingNASDAQ:CGIXCancer Genetics Inc
25/03/202108:16Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CGIXCancer Genetics Inc
25/03/202108:15GlobeNewswire Inc.Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniXNASDAQ:CGIXCancer Genetics Inc
18/03/202107:30GlobeNewswire Inc.Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business DevelopmentNASDAQ:CGIXCancer Genetics Inc
12/03/202108:30GlobeNewswire Inc.Cancer Genetics to Present at the Annual 33rd ROTH ConferenceNASDAQ:CGIXCancer Genetics Inc
04/03/202115:15GlobeNewswire Inc.Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences ConferenceNASDAQ:CGIXCancer Genetics Inc
26/02/202115:51Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:CGIXCancer Genetics Inc
16/02/202115:45GlobeNewswire Inc.Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq RulesNASDAQ:CGIXCancer Genetics Inc
10/02/202122:00GlobeNewswire Inc.Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq RulesNASDAQ:CGIXCancer Genetics Inc
08/02/202115:56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CGIXCancer Genetics Inc
 Showing the most relevant articles for your search:NASDAQ:CGIX

Su Consulta Reciente

NASDAQI
XBITQ
Bitwise Crypto Innovator...
BIT
P203L2
NLBNPIT203L2 20240621 450
USOTC
NNMX
Nanomix (CE)
BIT
P1XXZ2
NLBNPIT1XXZ2 20991231 63...
BOV
O1MC34R
Omnicom
NASDAQ
PLAO
Patria Latin American Op...
NASDAQ
DCBO
Docebo
COIN
YTCUSD
DOWI
E1BSC
DJ Europe Basic Materials
COIN
DMSEUR
USOTC
EBCOY
Ebara (PK)
DBI
3BTT
General All Share Kurs
BIT
NSCIT000GVL1
Irland
EU
MLAZR
The Azur Selection
ASX
LOT
Lotus Resources
BOV
MGLUV175
MGLUV175 Ex:1,74
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados